A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/215 (2006.01) A61K 31/382 (2006.01) A61K 31/554 (2006.01) A61K 31/557 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2337349
Combinations of a prostaglandin, prostaglandin derivative, hypotensive lipid derived from a prostaglandin or prostaglandin derivative or an ophthalmologically acceptable salt thereof and a topical carbonic anhydrase inhibitor or an ophthalmologically acceptable salt thereof are particularly useful in the treatment of ocular hypertension and glaucoma. The combinations are characterized by an improved effect and reduced side-effects.
La présente invention concerne des combinaisons d'une prostaglandine, d'un dérivé de prostaglandine, d'un lipide hypotenseur dérivé d'une prostaglandine ou d'un dérivé de prostaglandine ou d'un sel ophtalmologiquement acceptable de ceux-ci et d'un inhibiteur topique de l'anhydrase carbonique ou d'un sel ophtalmologiquement acceptable de celui-ci, qui sont utilisées en particulier dans le traitement de l'hypertension oculaire et du glaucome. Ces combinaisons sont caractérisées par un effet amélioré et des effets secondaires réduits.
Ponticello Gerald S.
Sugrue Michael F.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Ophthalmic compositions for treating ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions for treating ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions for treating ocular hypertension will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1787598